Life Sciences Seed Fund IPA
About the Fund
The Life Sciences Seed Fund IPA was created in May 2015. The Fund operates as an investment partnership that is controlled by the Investment Committee including representatives of RVC Seed Fund, KSI Ventures LLC, and the managing partner of the Fund. The Fund is searching for projects, helping them in organizing operations, and assuming management risks. The fund will invest into early stage projects on living systems: biomedical, pharmaceutical, cell, genomic, agrobio and neurotechnologies as well as bioengineering.
The Fund's size is RUB 133.6 mln. The investment period of the Life Sciences Seed Fund IPA is six years. It is allowed to increase the Fund's capital before the expiry of the investment period.
Tasks of the Fund
To develop early stage life science projects. To determine the most attractive business models and scale them, using capabilities and competences of KSI Ventures as a member of the Severny biopharmaceutical cluster. This will ensure access to the modern research facilities of MIPT, the leading technical university in the country, to pre-clinical and clinical centres of the cluster, and to the opportunities of direct communication with manufacturers of drugs and medical devices.
Basic parameters of the Fund
- It was founded in May 2015
- The volume of assets managed is RUB 133.6 mln.
- The investment period is six years.
- Additional capitalization is allowed.
- The Fund's form of organisation is an investment partnership consisting of RVC Seed Fund and KSI Ventures LLC (the managing partner).
Contacts
Bld. 5, Permovayskatya Str., Dolgoprudnyi, 141700, Moscow Region, Russia
+7 (495) 408-42-00